FOXP3 and inflammatory bowel disease: The formal proof that such polyclonal anergy-derived Foxp3+ Treg cells could be protective was obtained by usingin vivo models of inflammatory bowel disease and autoimmune arthritis in which the adoptive transfer of anergy-derived Foxp3+ Treg cells suppressed disease development5.